NEW TREATMENT FOR DRY MACULAR DEGENERATION – LOOKING FOR VOLUNTEERS
Age-related Macular degeneration (AMD) is a common eye disease that can lead to vision loss. At MVO we are testing a new treatment for the “dry” form of AMD. This therapy is the first clinically-proven, Health Canada-approved treatment to improve the visual function of patients affected by dry AMD.
We only have room for a limited number of volunteers for this painless, non-invasive treatment involving a patented microcurrent which is applied through the eyelids for 32 minutes per session. There will be no charge for the treatment sessions if you are selected for the clinical trial.
Contact us ASAP if you are interested* by emailing us at [email protected] or calling 403-851-2020.
* You must be a current patient of MVO. Not all patients with dry AMD are candidates. You will be screened for suitability and informed if you qualify for the clinical trial